Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
5.21
+0.15 (2.96%)
Jun 6, 2025, 4:00 PM - Market closed
Personalis Revenue
Personalis had revenue of $20.61M in the quarter ending March 31, 2025, with 5.53% growth. This brings the company's revenue in the last twelve months to $85.69M, up 15.57% year-over-year. In the year 2024, Personalis had annual revenue of $84.61M with 15.15% growth.
Revenue (ttm)
$85.69M
Revenue Growth
+15.57%
P/S Ratio
4.16
Revenue / Employee
$374,210
Employees
229
Market Cap
460.17M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
PSNL News
- 3 days ago - Personalis' NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCO - Business Wire
- 4 days ago - New Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for Relapse - Business Wire
- 16 days ago - Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection - Business Wire
- 23 days ago - Personalis to Participate at the Craig-Hallum 22nd Annual Investor Conference - Business Wire
- 4 weeks ago - Personalis, Inc. (PSNL) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Personalis Reports First Quarter 2025 Financial Results - Business Wire
- 5 weeks ago - Personalis' NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study - Business Wire
- 6 weeks ago - Personalis to Announce First Quarter 2025 Financial Results - Business Wire